Last reviewed · How we verify

NCT03424993

Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure

Completed Phase 4 Last updated 28 October 2024
What this trial tests

Phase 4 trial testing Dietary Sodium Restriction in Healthy in 100 participants. Completed in 10 June 2024.

Timeline
21 January 2018
Primary endpoint
10 June 2024
10 June 2024

Quick facts

Lead sponsorUniversity of Delaware
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment100
Start date21 January 2018
Primary completion10 June 2024
Estimated completion10 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Delaware

Who can join

Adults 21 to 45, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University of Delaware trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03424993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing